Role of micronutrients in Alzheimer's disease: Review of available evidence

被引:4
|
作者
Fei, Hong-Xin [1 ]
Qian, Chao-Fan [1 ]
Wu, Xiang-Mei [1 ]
Wei, Yu-Hua [1 ]
Huang, Jin-Yu [1 ,2 ,3 ]
Wei, Li-Hua
机构
[1] Guangxi Univ Sci & Technol, Dept Pathol, Liuzhou 545000, Guangxi Zhuang, Peoples R China
[2] Guangxi Univ Sci & Technol, Dept Neurol, Affiliated Hosp 1, Liuzhou 545000, Guangxi Zhuang, Peoples R China
[3] Guangxi Univ Sci & Technol, Dept Neurol, Affiliated Hosp 1, 124 Yuejin Rd, Liuzhou, Guangxi Zhuang, Peoples R China
关键词
Alzheimer's disease; Iron; Micronutrient; Zinc; IRON; AGGREGATION; SELENIUM; ZINC;
D O I
10.12998/wjcc.v10.i22.7631
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alzheimer's disease (AD) is one of the most common age-related neurodegenerative disorders that have been studied for more than 100 years. Although an increased level of amyloid precursor protein is considered a key contributor to the development of AD, the exact pathogenic mechanism remains known. Multiple factors are related to AD, such as genetic factors, aging, lifestyle, and nutrients. Both epidemiological and clinical evidence has shown that the levels of micronutrients, such as copper, zinc, and iron, are closely related to the development of AD. In this review, we summarize the roles of eight micronutrients, including copper, zinc, iron, selenium, silicon, manganese, arsenic, and vitamin D in AD based on recently published studies.
引用
收藏
页码:7631 / 7641
页数:11
相关论文
共 50 条
  • [31] The Potential Utility of Prebiotics to Modulate Alzheimer's Disease: A Review of the Evidence
    Kang, Jea Woo
    Zivkovic, Angela M.
    MICROORGANISMS, 2021, 9 (11)
  • [32] 1995 progress report on Alzheimer's disease available
    不详
    N&HC-PERSPECTIVES ON COMMUNITY, 1996, 17 (02): : 94 - 95
  • [33] Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review
    Yu, Chao-Chao
    Du, Yan-Jun
    Wang, Shu-Qin
    Liu, Le-Bin
    Shen, Feng
    Wang, Li
    Lin, Yuan-Fang
    Kong, Li-Hong
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [34] Level of evidence for case management in Alzheimer's disease: a literature review
    Somme, Dominique
    Carrier, Sebastien
    Trouve, Helene
    Gagnon, Dominique
    Dupont, Olivier
    Couturier, Yves
    Saint-Jean, Olivier
    PSYCHOLOGIE & NEUROPSYCHIATRIE DU VIEILLISSEMENT, 2009, 7 : 29 - 39
  • [35] Should we screen for Alzheimer's disease? A review of the evidence for and against screening for Alzheimer's disease in primary care practice
    Solomon, PR
    Murphy, CA
    GERIATRICS-US, 2005, 60 (11): : 26 - 31
  • [36] A REVIEW ON ALZHEIMER'S DISEASE
    Jyothi, N.
    Ramya, B.
    Kumar, G. Sai
    Navya, G.
    Bramarambha, N.
    Maisara, Sumaiya
    RajeswarDutt, K.
    Rao, K. N., V
    Reddy, K. Bali
    Krishna, N. Shiva
    Jyothi, K. Nava
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (04): : 7396 - 7402
  • [37] A critical review of available measurement tools for assessing memory enhancers in patients with Alzheimer's disease
    Poitrenaud, J
    Kalafat, M
    Israel, L
    Guez, D
    REVUE DE MEDECINE INTERNE, 1997, 18 (01): : 59 - 71
  • [38] Thematic Review Series: ApoE and Lipid Homeostasis in Alzheimer's Disease Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies
    Shinohara, Mitsuru
    Tachibana, Masaya
    Kanekiyo, Takahisa
    Bu, Guojun
    JOURNAL OF LIPID RESEARCH, 2017, 58 (07) : 1267 - 1281
  • [39] The role of fingolimod in Alzheimer's disease: A systematic review of preclinical studies
    Angelopoulou, E.
    Piperi, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 347 - 347
  • [40] The Role of Copper in Alzheimer's Disease Etiopathogenesis: An Updated Systematic Review
    Sabalic, Angela
    Mei, Veronica
    Solinas, Giuliana
    Madeddu, Roberto
    TOXICS, 2024, 12 (10)